Clinical Trial Update: Pilot Study of Triheptanoin in Patients With Glucose Transporter 1 Deficiency Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 pilot study of triheptanoin in patients with glucose transporter type 1 deficiency syndrome is described, with the trial status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Transporter Type Deficiency Syndrome

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: University of British Columbia | Conditions: Glucose Transporter Type 1 Deficiency Syndrome | Phase 2 | Status: UNKNOWN